Synthesis of aristolactam analogues and evaluation of their antitumor activity

Bioorg Med Chem Lett. 2009 Jun 1;19(11):3036-40. doi: 10.1016/j.bmcl.2009.04.020. Epub 2009 Apr 10.

Abstract

A series of natural aristolactams and their analogues have been prepared and evaluated for antitumor activity against human cancer cells, including multi-drug resistant cell lines. Naturally occurring aristolactams, such as aristolactam BII (cepharanone B), aristolactam BIII, aristolactam FI (piperolactam A), N-methyl piperolactam A, and sauristolactam showed moderate antitumor activities in selected cell lines. However, several synthetic aristolactam derivatives exhibited potent antitumor activities against a broad array of cancer cell lines with GI(50) values in the submicromolar range.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / toxicity
  • Aporphines / chemical synthesis
  • Aporphines / chemistry
  • Aporphines / toxicity
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
  • Heterocyclic Compounds, 4 or More Rings / chemistry
  • Heterocyclic Compounds, 4 or More Rings / toxicity
  • Humans
  • Lactams / chemical synthesis*
  • Lactams / chemistry
  • Lactams / toxicity

Substances

  • Antineoplastic Agents
  • Aporphines
  • Heterocyclic Compounds, 4 or More Rings
  • Lactams
  • aporphine